Cargando…

International Multisite Study of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Drug Proarrhythmic Potential Assessment

To assess the utility of human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) as an in vitro proarrhythmia model, we evaluated the concentration dependence and sources of variability of electrophysiologic responses to 28 drugs linked to low, intermediate, and high torsades de point...

Descripción completa

Detalles Bibliográficos
Autores principales:	Blinova, Ksenia, Dang, Qianyu, Millard, Daniel, Smith, Godfrey, Pierson, Jennifer, Guo, Liang, Brock, Mathew, Lu, Hua Rong, Kraushaar, Udo, Zeng, Haoyu, Shi, Hong, Zhang, Xiaoyu, Sawada, Kohei, Osada, Tomoharu, Kanda, Yasunari, Sekino, Yuko, Pang, Li, Feaster, Tromondae K., Kettenhofen, Ralf, Stockbridge, Norman, Strauss, David G., Gintant, Gary
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6226030/ https://www.ncbi.nlm.nih.gov/pubmed/30257217 http://dx.doi.org/10.1016/j.celrep.2018.08.079

Ejemplares similares

Electrophysiological Characteristics of Human iPSC-Derived Cardiomyocytes for the Assessment of Drug-Induced Proarrhythmic Potential
por: Yamamoto, Wataru, et al.
Publicado: (2016)

Acute effects of cardiac contractility modulation on human induced pluripotent stem cell–derived cardiomyocytes
por: Feaster, Tromondae K., et al.
Publicado: (2021)

Human cardiomyocytes are more susceptible to irreversible electroporation by pulsed electric field than human esophageal cells
por: Casciola, Maura, et al.
Publicado: (2022)

Human in vitro neurocardiac coculture (iv NCC) assay development for evaluating cardiac contractility modulation
por: Narkar, Akshay, et al.
Publicado: (2022)

Human in vitro assay for irreversible electroporation cardiac ablation
por: Casciola, Maura, et al.
Publicado: (2023)

Acute effects of cardiac contractility modulation stimulation in conventional 2D and 3D human induced pluripotent stem cell-derived cardiomyocyte models
por: Feaster, Tromondae K., et al.
Publicado: (2022)

Assay for evaluation of proarrhythmic effects of herbal products: Case study with 12 Evodia preparations
por: Baltov, Bozhidar, et al.
Publicado: (2023)

Identification of Drug-Induced Multichannel Block and Proarrhythmic Risk in Humans Using Continuous T Vector Velocity Effect Profiles Derived From Surface Electrocardiograms
por: Bystricky, Werner, et al.
Publicado: (2020)

Cross-Site Reliability of Human Induced Pluripotent stem cell-derived Cardiomyocyte Based Safety Assays Using Microelectrode Arrays: Results from a Blinded CiPA Pilot Study
por: Millard, Daniel, et al.
Publicado: (2018)

Is Cardiac Resynchronisation Therapy Proarrhythmic?
por: Leyva, Francisco, et al.
Publicado: (2008)

In silico models for evaluating proarrhythmic risk of drugs
por: Hwang, Minki, et al.
Publicado: (2020)

Ginkgo Biloba: Plant-Based Proarrhythmic Potential?
por: Natour, Sami J., et al.
Publicado: (2020)

Bifurcations and Proarrhythmic Behaviors in Cardiac Electrical Excitations
por: Tsumoto, Kunichika, et al.
Publicado: (2022)

Proarrhythmic changes in human cardiomyocytes during hypothermia by milrinone and isoprenaline, but not levosimendan: an experimental in vitro study
por: Selli, Anders Lund, et al.
Publicado: (2023)

Effects of diclofenac on ventricular muscle repolarization: proarrhythmic implications
por: Jost, Norbert, et al.
Publicado: (2011)

Anti‐malarial drugs: Mechanisms underlying their proarrhythmic effects
por: Saadeh, Khalil, et al.
Publicado: (2022)

Mechanistic Model‐Informed Proarrhythmic Risk Assessment of Drugs: Review of the “CiPA” Initiative and Design of a Prospective Clinical Validation Study
por: Vicente, Jose, et al.
Publicado: (2017)

Considerations for an In Vitro, Cell-Based Testing Platform for Detection of Drug-Induced Inotropic Effects in Early Drug Development. Part 2: Designing and Fabricating Microsystems for Assaying Cardiac Contractility With Physiological Relevance Using Human iPSC-Cardiomyocytes
por: Ribeiro, Alexandre J. S., et al.
Publicado: (2019)

Prevention of Pazopanib-Induced Prolonged Cardiac Repolarization and Proarrhythmic Effects
por: Akman, Tulay, et al.
Publicado: (2014)

An initial map of chromosomal segmental copy number variations in the chicken
por: Wang, Xiaofei, et al.
Publicado: (2010)

Signs of Cardiac Autonomic Imbalance and Proarrhythmic Remodeling in FTO Deficient Mice
por: Carnevali, Luca, et al.
Publicado: (2014)

Retrospective study of proarrhythmic effects of levosimendan during the therapy of heart failure
por: Zima, E, et al.
Publicado: (2007)

Assessment of proarrhythmic activity of chloroquine in in vivo and ex vivo rabbit models
por: Khobragade, Shailaja B., et al.
Publicado: (2013)

Proarrhythmic Remodeling of Calcium Homeostasis in Cardiac Disease; Implications for Diabetes and Obesity
por: Hamilton, Shanna, et al.
Publicado: (2018)

Proarrhythmic Electrical Remodeling by Noncardiomyocytes at Interfaces With Cardiomyocytes Under Oxidative Stress
por: Zhao, Yali, et al.
Publicado: (2021)

Proarrhythmic effect of radiofrequency catheter ablation on the right ventricular moderator band
por: John, Roy M., et al.
Publicado: (2022)

Proarrhythmic Remodeling of Atrial Myocyte Ca(2+) Handling in Atrial Fibrillation
por: Houser, Steven R.
Publicado: (2023)

Investigation of proarrhythmic effect of high sugammadex doses: an experimental animal study
por: Demir, Emin Tunç, et al.
Publicado: (2022)

Proarrhythmic risk and determinants of cardiac autonomic dysfunction in collagen-induced arthritis rats
por: Lin, Ting-Tse, et al.
Publicado: (2016)

Proarrhythmic remodelling of the right ventricle in a porcine model of repaired tetralogy of Fallot
por: Benoist, David, et al.
Publicado: (2017)

Beta-Adrenergic Receptor Stimulation Modulates the Cellular Proarrhythmic Effects of Chloroquine and Azithromycin
por: Sutanto, Henry, et al.
Publicado: (2020)

Introduction to in silico model for proarrhythmic risk assessment under the CiPA initiative
por: Park, Jin-Sol, et al.
Publicado: (2019)

Rapid Assessment of Proarrhythmic Potential Using Human iPSC-Derived Cardiomyocytes
por: Geiger, Robert M., et al.
Publicado: (2020)

In silico Identification of Disrupted Myocardial Calcium Homeostasis as Proarrhythmic Trigger in Arrhythmogenic Cardiomyopathy
por: Lyon, Aurore, et al.
Publicado: (2021)

Chlorpyrifos inhibits neural induction via Mfn1-mediated mitochondrial dysfunction in human induced pluripotent stem cells
por: Yamada, Shigeru, et al.
Publicado: (2017)

Effects of proarrhythmic drugs on relaxation time and beating pattern in rat engineered heart tissue
por: Eder, Alexandra, et al.
Publicado: (2014)

L-Type Calcium Channel Inhibition Contributes to the Proarrhythmic Effects of Aconitine in Human Cardiomyocytes
por: Wu, Jianjun, et al.
Publicado: (2017)

Resveratrol enhances the inotropic effect but inhibits the proarrhythmic effect of sympathomimetic agents in rat myocardium
por: Hernandez-Cascales, Jesús
Publicado: (2017)

Identification of Na(+)/K(+)-ATPase inhibition-independent proarrhythmic ionic mechanisms of cardiac glycosides
por: Koh, Cai Hong, et al.
Publicado: (2017)

Global Sensitivity Analysis of Ventricular Myocyte Model-Derived Metrics for Proarrhythmic Risk Assessment
por: Parikh, Jaimit, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_338rs8j6jog13eutu1ojc4mprs